Using data from four phase 3 clinical trials, researchers analyzed the impact of subcutaneous semaglutide, administered once weekly, on participants' health-related quality of life.
Using data from four phase 3 clinical trials, researchers analyzed the impact of subcutaneous semaglutide, administered once weekly, on participants' health-related quality of life.
Using data from four phase 3...